Suppr超能文献

分泌型磷脂酶 A2:儿科急诊就诊的发热儿童感染的标志物。

Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED.

机构信息

Children's Hospital and Research Center, Department of Emergency Medicine, Oakland, CA 94618, USA.

出版信息

Am J Emerg Med. 2011 Nov;29(9):1163-8. doi: 10.1016/j.ajem.2010.06.024. Epub 2010 Aug 13.

Abstract

BACKGROUND

Fever is a common presenting complaint to the emergency department (ED), and the evaluation of the febrile child remains a challenging task.

OBJECTIVE

The aim of this study was to examine the relationship between secretory phospholipase A2 (sPLA2) and infection in febrile children.

METHODS

A prospective convenience sample of children presenting with fever to an urban pediatric ED were studied. Blood and urine cultures, a complete blood count, and serum concentrations of sPLA2 were obtained, and patients were compared based on their final diagnosis of either a viral or bacterial infection.

RESULTS

In the 76 patients enrolled, 60 were diagnosed with a viral infection, 14 with a bacterial infection, 1 with Kawasaki disease, and 1 with acute lymphoblastic leukemia. The difference in the serum concentration of sPLA2 in patients with viral infections (22 ± 34 ng/mL) versus those with bacterial infections (190 ± 179 ng/mL) was statistically significant (P < .0001). Receiver operator characteristic curve analysis revealed that sPLA2 was more accurate at predicting bacterial infection (area under the curve = 0.89) than the total white blood cell count (area under the curve = 0.71) and that a value of more than 20 ng/mL had a sensitivity of 93%, specificity of 67%, positive predictive value of 39%, and negative predictive value of 97%.

CONCLUSION

Secretory phospholipase A2 differs significantly in children with viral versus bacterial infection and seems to be a reliable screening test for bacterial infection in febrile children.

摘要

背景

发热是急诊科常见的就诊主诉,儿童发热的评估仍然是一项具有挑战性的任务。

目的

本研究旨在探讨分泌型磷脂酶 A2(sPLA2)与发热儿童感染之间的关系。

方法

对因发热就诊于城市儿科急诊科的患儿进行前瞻性便利抽样研究。采集血、尿培养物、全血细胞计数和 sPLA2 血清浓度,并根据最终诊断为病毒或细菌感染将患者进行比较。

结果

在纳入的 76 例患者中,60 例诊断为病毒感染,14 例诊断为细菌感染,1 例诊断为川崎病,1 例诊断为急性淋巴细胞白血病。病毒感染患者(22 ± 34 ng/mL)与细菌感染患者(190 ± 179 ng/mL)血清 sPLA2 浓度差异具有统计学意义(P <.0001)。受试者工作特征曲线分析显示,sPLA2 预测细菌感染的准确性(曲线下面积为 0.89)优于白细胞总数(曲线下面积为 0.71),且 sPLA2 值大于 20 ng/mL 时,其灵敏度为 93%,特异性为 67%,阳性预测值为 39%,阴性预测值为 97%。

结论

病毒感染与细菌感染儿童的分泌型磷脂酶 A2 差异显著,sPLA2 似乎是发热儿童细菌感染的一种可靠筛选试验。

相似文献

1
Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED.
Am J Emerg Med. 2011 Nov;29(9):1163-8. doi: 10.1016/j.ajem.2010.06.024. Epub 2010 Aug 13.
3
Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.
JAMA Pediatr. 2016 Jan;170(1):62-9. doi: 10.1001/jamapediatrics.2015.3210.
5
Value of white cell count in predicting serious bacterial infection in febrile children under 5 years of age.
Arch Dis Child. 2014 Jun;99(6):493-9. doi: 10.1136/archdischild-2013-304754. Epub 2014 Jan 9.
7
Immature neutrophils in the blood smears of young febrile children.
Arch Pediatr Adolesc Med. 1999 Mar;153(3):261-6. doi: 10.1001/archpedi.153.3.261.
9
Duration of fever and markers of serious bacterial infection in young febrile children.
Pediatr Int. 2007 Feb;49(1):31-5. doi: 10.1111/j.1442-200X.2007.02316.x.

引用本文的文献

1
Hyperinflammation, apoptosis, and organ damage.
Exp Biol Med (Maywood). 2022 Jul;247(13):1112-1123. doi: 10.1177/15353702221090454. Epub 2022 Apr 27.
2
Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).
Exp Biol Med (Maywood). 2021 Dec;246(23):2543-2552. doi: 10.1177/15353702211028560. Epub 2021 Jul 13.
3
Measurement of a Novel Biomarker, Secretory Phospholipase A2 Group IIA as a Marker of Sepsis: A Pilot Study.
J Emerg Trauma Shock. 2018 Apr-Jun;11(2):135-139. doi: 10.4103/JETS.JETS_29_17.
4
Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review.
PLoS One. 2016 Aug 3;11(8):e0160278. doi: 10.1371/journal.pone.0160278. eCollection 2016.

本文引用的文献

2
Procalcitonin in young febrile infants for the detection of serious bacterial infections.
Pediatrics. 2008 Oct;122(4):701-10. doi: 10.1542/peds.2007-3503.
3
Procalcitonin in pediatrics for differentiation of bacterial and viral infections.
Intensive Care Med. 2000 Mar;26 Suppl 2:S178-81. doi: 10.1007/BF02900734.
6
Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours.
J Am Coll Surg. 2005 Feb;200(2):173-8. doi: 10.1016/j.jamcollsurg.2004.10.010.
7
Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children.
Curr Opin Pediatr. 2005 Feb;17(1):56-61. doi: 10.1097/01.mop.0000151781.13635.70.
8
Procalcitonin as an early marker of infection in neonates and children.
Lancet Infect Dis. 2004 Oct;4(10):620-30. doi: 10.1016/S1473-3099(04)01146-6.
9
[Use of procalcitonin at the pediatric emergency room].
Arch Pediatr. 2004 Jun;11(6):582-4. doi: 10.1016/j.arcped.2004.03.053.
10
The role of secretory phospholipase A2 in acute chest syndrome.
Cell Mol Biol (Noisy-le-grand). 2004 Feb;50(1):87-94.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验